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BACKGROUND: Early-onset atopic dermatitis (AD) is a particular phenotype that 37 
may convey a risk of developing multiple sensitizations to allergens but little is known 38 
about the pathway of sensitization. The aims of this study were to describe the 39 
natural history of sensitization to allergens for this phenotype and to identify the most 40 
predictive marker associated with the risk of developing sensitization to inhaled 41 
allergens in a well-selected cohort of infants with AD. METHODS: Infants with active 42 
AD were enrolled and prospectively explored for biological markers of atopy every 43 
year until the age of 6 years. Allergic sensitization was defined as the presence of 44 
positive specific IgEs to allergens and multiple sensitizations as being sensitized to 45 
≥2 allergens. Elevated blood eosinophilia was defined as an eosinophil blood count 46 
≥470 eosinophils/mm3 and elevated total IgE as a serum IgE level ≥45 kU/L.  47 
RESULTS: 229 infants were included. Elevated blood eosinophilia was observed at 48 
baseline in 60 children (26.2%) and elevated total IgE in 85 (37.1%). When elevated 49 
at baseline, eosinophilia and IgE levels remained significantly higher during the 50 
follow-up period. Sensitization to food allergens decreased from 58% to 34% 51 
whereas sensitization to inhaled allergens increased over time from 17% to 67%. 52 
Initial multiple sensitizations to food allergens were the most predictive factor for the 53 
risk of developing sensitization to inhaled allergens at 6 years (OR 3.72 [1.68-8.30] 54 
p<0.001). CONCLUSIONS:  In the early-onset AD phenotype, multiple sensitization 55 
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to food allergens conveys a higher risk of sensitization to inhaled allergens than 56 
single sensitization. 57 
Key words Atopic dermatitis, sensitization, food allergens, inhaled allergens, 58 
phenotypes, cohort 59 
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Introduction 89 
Atopic dermatitis (AD), which often begins in infancy, is a chronic inflammatory 90 
disorder of the skin that affects 10 to 30% of children {1}. Prevalence of sensitization 91 
to inhaled allergens in the general population is between 16 to 25% [2]. It is 92 
suspected that there is a link between AD and the occurrence of sensitization to 93 
inhaled allergens during childhood. This could be because of percutaneous entry of  94 
the allergens through an impaired skin barrier due to inflamation. Moreover, early-95 
onset AD, as well as the severity of AD, has been shown to be associated with a risk 96 
of sensitization to food allergens at 3 months of age [3]. Sensitization to food 97 
allergens in birth cohorts, particularly elevated egg-specific IgE, has also been shown 98 
to be a risk marker for sensitization to inhaled allergens later in life {4}. Furthermore, 99 
sensitization to inhaled allergens can predict the occurrence of respiratory disease 100 
which can start years before the first symptoms of allergic rhinitis or asthma [5]. All in 101 
all, AD could be the first step leading to asthma, particularly in children with severe 102 
[6] or early-onset AD [7]. However, the early-onset and severe phenotype of AD is 103 
quite rare; e.g., in Flohr et al.'s study  {3} conducted in 619 infants from a population 104 
of breastfed infants, only 3.6% had severe AD and 5.4% were sensitized to at least 105 
one food allergen. This makes it relatively difficult to explore this phenotype. We 106 
therefore set out to explore a cohort of children suffering from early-onset AD  from 107 
the prospective longitudinal ORCA (Observatory of Respiratory risks linked with 108 
Cutaneous Atopy) study to try to describe this phenotype more precisely.  The 109 
objectives of the present analysis were to describe the natural history of sensitization 110 
in this cohort and then to identify the best marker associated with the risk of 111 
developing sensitization to inhaled allergens. 112 
Methods  113 
Design  114 
Patients were part of the ten-year (2002-2012) Observatory of Respiratory risks 115 
linked with Cutaneous Atopy (ORCA) Study resulting from the collaboration between 116 
two tertiary care centers, the Allergology Department at the Armand Trousseau 117 
Children‘s Hospital and the Dermatology Department at the Saint-Louis Hospital, 118 
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both in Paris, France. The study prospectively included children with AD referred to 119 
the Saint-Louis Hospital by a primary care physician.  120 
Ethics 121 
Parents of each child provided written informed consent at inclusion. The protocol 122 
was endorsed by the Institutional Review Board of the Medical Ethics Committee on 123 
Research of the Saint-Louis Hospital. Data were collected for the study with respect 124 
to the confidentiality of patient records. 125 
Inclusion criteria We considered for inclusion all the children meeting the following 126 
criteria: i. aged younger than 12 months, ii. with an active AD diagnosed by a 127 
dermatologist according to the United Kingdom Working Party criteria (UKWP) {8} 128 
and ISAAC questionnaire {9}, iii. without a history of wheezing. 129 
Data collection at inclusion 130 
Clinical data collected were: 131 
1. Gender  132 
2. Active AD defined by ISAAC questionnaire {9} and AD severity assessed by 133 
the SCORAD questionnaire [10]. We defined a low severity group for children 134 
when the SCORAD was under 15, a medium severity group when the 135 
SCORAD was between 15 and 40, and a high severity group when the 136 
SCORAD was above 40. 137 
3. Any documented food allergy defined by relevant allergic symptoms following 138 
consumption of a food allergen associated with a sensitization to the same 139 
allergen.  140 
Biological markers of atopy measured in peripheral blood included: 141 
1. Specific IgEs for inhaled and food allergens (ImmunoCAP Phadiatop Infant; 142 
Uppsala, Sweden). Sensitization was defined as a specific IgE concentration 143 
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≥0.35 kU/L in serum against one of the following inhaled and food allergens: 144 
house dust mite (HDM), cat and dog dander, pollens (birch tree, timothy grass, 145 
mugwort), cockroaches; cow's milk, hen’s egg, peanut, soy, fish and wheat. 146 
Multiple sensitizations were defined as at least two positive specific IgEs to 147 
allergens.   148 
2. Other biological markers such as blood eosinophilia (cell counting by 149 
automated Sysmex; France), and total IgE (measured by ImmunoCAP; 150 
Uppsala, Sweden). Thresholds were used to define increased levels: 151 
increased blood eosinophilia was defined as a concentration of 470 152 
eosinophils/mm3 or more and increased total IgE as a concentration of 45 kU/L 153 
or more [11].  154 
Prospective data collection 155 
Children were followed up on biological parameters at the age of 6 months and then 156 
annually until the age of 6 years. Biological parameters assessed at each visit were: 157 
specific IgE levels against inhaled and food allergens; blood eosinophilia;  and total 158 
IgE levels, as described above. 159 
 160 
Statistical analysis 161 
All the results were calculated from the export database. Statistical analysis was 162 
performed using the Open Source R software (> R 2.13.1) [R Development Core 163 
Team (2009). R: A language and environment for statistical computing. R Foundation 164 
for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-165 
project.org.]. Observed distributions of variables are described as numbers and 166 
percentages for categorical variables and means, standard deviations and ranges for 167 
continuous variables. The baseline characteristics of the patients were compared by 168 
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the chi-square test or Fisher's exact test for categorical variables and Welsh’s 169 
student test for continuous variables. The variables defining severity of AD were 170 
discretized in three classes according to the SCORAD questionnaire as described 171 
above. Clinical and biological features associated with the risk of developing 172 
sensitization to inhaled allergens by the end of the follow-up period were calculated 173 
with a logistic regression model. These prognostic factors (p<0.2) were then included 174 
in the multivariate analysis. Estimated OR are given with a 95% Confidence Interval. 175 
Survival analysis, describing time to sensitization (sensitization to inhaled allergens), 176 
was performed by Kaplan–Meier analysis. For Kaplan–Meier analysis, we analysed 177 
all clinical events by time to first event.  178 
 179 
 180 
181 
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Results  182 
Three hundred children were initially considered for inclusion. Twenty-nine were 183 
excluded (21 for lack of parental consent, 7 for a previous history of wheezing and 184 
one for gluten intolerance). 42 were lost to follow-up immediately after the inclusion 185 
visit and were not included in the analysis. The remaining 229 patients were included 186 
for baseline characteristics analysis. 190 completed the last visit and formed the final 187 
sample. The baseline characteristics of the children who were not included in the 188 
final analysis did not differ from those of the final sample (data not shown). Figure 1 189 
summarizes the patients flowchart.  190 
Descriptive data at baseline  191 
Clinical parameters. There were 134 boys (58.5%) and the mean age was 6.5±2.7 192 
months (mean ±SD). Mean SCORAD was 34.2±21.0 (mean±SD). Food allergy was 193 
present in 6% (13/229) of the children. 173 children (75.6%) had a parental history of 194 
atopy.  195 
Biological markers  196 
Blood eosinophilia. Increased levels of blood eosinophilia were observed in 26.2 % 197 
(59/225) with an average value of 356.2±548.7/mm3 (mean ±SD).   198 
Total IgE. Increased total IgE was observed in 36.9 % (83/225) with an average 199 
value of 111.2±316.1 KU/L (mean ±SD).    200 
Specific IgE. 58% (132/229) of the children had sensitization to food allergens and 201 
37 % (86/229) multiple sensitizations. Hen’s egg, cow's milk, peanut represented 202 
95% (125/132) of sensitization to food allergens (hen’s egg 44%, cow’s milk 26%, 203 
peanut 25%, fish 4%, wheat 3%, soy 2.2%). Seventeen percent (40/229) of the 204 
children were sensitized to at least one inhaled allergen. Cat dander represented 205 
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52% (21/40) of sensitization to inhaled allergens, HDM and dog dander 17 % (7/40), 206 
all the pollens 12% (5/40) and cockroaches 2.5 % (1/40).  207 
Descriptive atopic biological markers during the follow-up period 208 
Changes in blood eosinophilia. Analysis by a linear mixed model taking the level of 209 
blood eosinophilia at baseline variable as an interaction with time showed that levels 210 
of eosinophilia remained on average significantly higher in children with an increased 211 
level of blood eosinophilia at baseline, compared to those with a low level at baseline 212 
(+705/mm3 vs +76.1/mm3 over the follow-up period, respectively, p<0.001). 213 
Changes in total IgE. Analysis based on a linear mixed model of the total IgE level 214 
variable considered as an interaction with time showed that children with an 215 
increased total IgE at baseline had significantly higher average values throughout 216 
follow-up than the children in whom the initial total IgE value was normal (+284.6 217 
kU/L vs +39.2 kU/L over the follow-up period, p<0.001) (Figure 2). 218 
Changes in specific IgEs.  219 
Overall, sensitization to food allergens decreased from 58% (132/229) at inclusion to 220 
34% (66/195) at the end of the follow-up period. In contrast, the percentage of 221 
children sensitized to inhaled allergens increased over time from 17% (39/229) at 222 
inclusion to 67% (130/195) at the end of follow up. 46% (90/195) of the children were 223 
sensitized to both food and inhaled allergens at the end of the follow-up compared to 224 
17% (39/229) at baseline. More precisely, at the end of the follow-up period 225 
sensitization to inhaled allergens consisted of timothy grass pollens (30%), HDM 226 
(28%) while sensitization to cat dander decreased to 18%. Sensitization to dog 227 
dander remained stable at around 5%, as well as birch pollen that represented 18% 228 
of sensitizations. Hen’s egg, cow's milk and peanut together represented 86% of 229 
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sensitizations to food allergens, with 35%, 29% and 22% for peanut, egg and cow's 230 
milk respectively (Figure 3). 231 
 232 
Factors associated with the risk of sensitization to inhaled allergens at the end 233 
of the follow-up period 234 
In univariate analysis, clinical and biological markers were evaluated as risk factors 235 
for developing inhaled sensitization (Table 1). No clinical parameters (such as 236 
severity of atopic dermatitis or food allergy) were found to be risk factors. In contrast, 237 
elevated total IgE at baseline emerged as a risk factor for developing sensitization to 238 
inhaled allergens at the end of follow up (OR 2.94 {1.58-5.47} p< 0.001).  One 239 
hundred infants (76.9%) sensitized to food allergens were sensitized to inhaled 240 
allergens at 6 years (OR 3.32 {1.90-5.84} p<0.001). More precisely, infants with 241 
multiple sensitizations to food allergens were more likely to be sensitized to inhaled 242 
allergens (OR 4.32 {2.22-8.40} p< 0.001) than infants with a single food sensitization 243 
(OR 2.20 {1.05-4.60} p=0.035). 244 
In multivariate analysis, only sensitization to food allergen remained a determinant 245 
and multiple food sensitizations were the most predicitve marker associated with the 246 
risk of developing sensitization to inhaled allergens at shool age (OR 3.72 {1.68-8.30} 247 
p<0.001). This was almost double than that for children with one food sensitization 248 
(OR 2.20 {1.01- 4.72} p=0.05) (Table 2).  249 
 250 
 251 
 252 
 253 
 254 
 255 
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Discussion  256 
The main result of this study is that multiple sensitizations to food allergens as 257 
opposed to a single sensitization, could be a predictor of sensitization to inhaled 258 
allergens in children suffering from early-onset AD. This finding leads to the 259 
emergence of a particular phenotype of sensitizations in early-onset AD.  260 
 261 
High T-helper cell 2 (Th2) dominant lymphocyte pattern exists in early-life and 262 
persists during preschool age   263 
We have shown that both elevated blood eosinophilia and elevated total IgE seem to 264 
follow a track during childhood for infants with a particular phenotype of AD. This 265 
corresponds to what is known as the extrinsic form of AD as opposed to the intrinsic 266 
form. While both forms are clinically identical, the former is characterized by high 267 
levels of specific IgEs.  Yamamoto et al. {12} reported significant differences in terms 268 
of heterogeneity of the interleukin 5 gene between AD with high and low blood 269 
eosinophil levels. Thus AD can present different clinical phenotypes-genotypes. 270 
There is considerable evidence that some individuals with AD present immune 271 
dysregulation, including increased serum IgE and allergen sensitization, and 272 
increased Th2 cytokine expression in eczematous lesions {13}. Genetic factors 273 
predispose atopic subjects to mount exaggerated Th2 responses {14} and to 274 
exaggerated abnormality of the epidermal barrier {15}, which may favor allergic 275 
sensitization.  Recently, Suárez-Fariñas et al. {16} demonstrated a significant 276 
correlation between IgE levels and SCORAD scores (r=0.76, p<10-5) only in patients 277 
with extrinsic AD.  278 
 279 
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Sensitizations to food allergens move  towards sensitizations to  inhaled 280 
allergens in some children suffering from early-onset AD  Extrinsic AD implies 281 
the presence of a Th2 lymphocyte pattern with a cytokine profile facilitating an IgE 282 
response to environmental antigens. It is therefore hardly surprising that early 283 
expression of IgE-mediated sensitization to food is accompanied by a high risk of 284 
sensitization to inhaled allergens. This fact is in accordance to results published from 285 
the DARC cohort, in which predominately sensitization to foods, however shifting 286 
toward inhalant allergens with age ( Eller E, Kjaer HF, Høst A, Andersen KE, 287 
Bindslev-Jensen C.Development of atopic dermatitis in the DARC birth cohort. 288 
Pediatr Allergy Immunol. 2010 Mar;21(2 Pt 1):307-14.)   289 
In the case of early-onset eczema, IgE sensitization often occurs weeks or months 290 
after the eczema lesions first appear, suggesting the allergens are first introduced 291 
through the skin. Once allergens have penetrated the skin barrier, they interface with 292 
antigen-presenting cells, which can then initiate a Th2 response by dendritic cells 293 
{17}. The ensuing cascade can result in a long-lasting response with sensitization of 294 
the host. Subsequent exposures can then lead to allergic rhinitis and asthma {18}. 295 
A recent larger birth cohort study demonstrated a strong association between food 296 
allergen sensitization, especially hen’s egg, and asthma development by age 6 years 297 
{19}. Our study therefore confirms that early-onset AD is often associated with 298 
sensitization to food allergens and more precisely multiple food sensitizations.  299 
 300 
Multiple food sensitizations are the most predictive biomarker of early 301 
sensitization to inhaled allergens  302 
These results validate our previous findings that there are multiple atopic phenotypes 303 
{20}. In the same way, Lazic et al. {21} recently validated his previous study 304 
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suggesting that allergic phenotypes change little over time, and that one phenotype 305 
with sensitization to a wide variety of allergens was much more likely to give rise to 306 
asthma during childhood. This class is relatively unfrequent, comprising 307 
approximately one third of the children who would be considered atopic by 308 
conventional criteria.  In the same manner, in a particular phenotype with early-onset 309 
AD, we have shown here that sensitization to food allergens conveys a high risk of 310 
sensitization to inhaled allergens rather when multiple than when unique. This finding 311 
supports the hypothesis that the clinical expression of allergic diseases does not 312 
merely depend on the presence of specific IgE antibodies, but rather on patterns of 313 
IgE responses over time. 314 
 315 
Strength and limitations of our study  316 
The strength of the study resides in the fact that it was a longitudinal prospective 317 
cohort in a highly selected population of infants with early-onset AD explored 318 
annually in a standardized manner. However, one limitation could be the rather small 319 
size of the cohort and the absence of a control group. However, as mentioned in the 320 
introduction, we selected a rare but potentially severe phenotype i.e., early-onset AD. 321 
In this context, the size of this selected population was greater than the number of 322 
patients suffering from this phenotype if selected from a large birth cohort. It would 323 
have been of interest to know if multiple food sensitizations could predict not only 324 
sensitization to inhaled allergens but also to severe allergic diseases such as 325 
persistent AD and mainly asthma. Nevertheless, inhaled sensitization has been 326 
found to be a strong predictor of asthma development and airway 327 
hyperresponsiveness up to school age, which is a strong risk factor for respiratory 328 
allergies {22. In the same manner, Kjaer HF et al showed that children with atopic 329 
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dermatitis, asthma, or rhinoconjunctivitis, and sensitization at 6 yr, were sensitized to 330 
food allergens to a large extent (53%, 42%, and 47%, respectively) already at 6 331 
months. This relationship will constitute our future research on this cohort. 332 
 333 
In conclusion, Our data have showed longitudinal changes in sensitization patterns 334 
of children with early-onset AD and more precisely that  multiple food sensitizations, 335 
rather than single food sensitization, conveys a high risk of sensitization to inhaled 336 
allergens at school age. It is thus important to identify this phenotype during infancy 337 
to optimize patient management.  338 
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Figure 1. Flow-chart of the study.  342 
Legend: AD atopic dermatitis, n number of patients, mean age at each visit is under brackets. 343 
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 344 
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Figure 2: Phenotypes of total IgE levels during the 72 months of follow up: changes in the low (<45 kU/L) and high (≥45 345 
kU/L) total IgE levels at inclusion. The horizontal lines of the box represent the lower, median and upper quartile, the hatched 346 
traits represent the values outside of the whiskers (the ends of the whiskers represent the lowest datum still within 1.5 interquartile 347 
range (IQR) of the lower quartile, and the highest datum still within 1.5 IQR of the upper quartile).    348 
 18  349 
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Figure 3:  Changes in each sensitization to food (A) and inhaled allergen (B) during the 72 months of the follow-up  350 
Changes are expressed in percentage of sensitized children. HDM house dust mite 351 
 352 
 20 
353 
 21 
Table 1: Estimated univariate OR of variables at baseline associated to sensitization to inhaled allergens at the end of 354 
follow up 355 
Covariables at baseline   Univariate models  
 Sensitization to inhaled 
allergens at 5 or 6 years N / N 
total 
OR (CI 95%)   p-value 
Eosinophilia level  
Low 
High 
 
94/150 
39/59 
 
1.00 
1.16 (0.62; 2.18) 
 
 
0.64 
Total IgE level 
Low 
High 
 
75/136 
65/83 
 
1.00 
2.94 (1.58; 5.47) 
 
 
0.0007 
Atopic Dermatitis score  
SCORAD <15 
15<SCORAD <40 
SCORAD >40 
 
24/45 
69/104 
54/80 
 
1.00 
1.72 (0.84; 3.51) 
1.82 (0.86; 3.84) 
 
 
0.13 
0.12 
Food allergy 
No 
Yes 
 
123/196 
10/13 
 
1.00 
1.98 (0.53; 7.42) 
 
 
0.31 
Sensitization to food allergens 
No 
Yes 
 
47/97 
100/132 
 
1.00 
3.32 (1.90; 5.84) 
 
 
<0.001 
Sensitization to food allergens 
No 
Single food sentization    
Multiple food sensitizations 
 
47/97 
31/46 
69/86 
 
1.00 
2.20 (1.05; 4.60) 
4.32 (2.22; 8.40) 
 
           
   0.035 
< 0.001 
Sensitization to inhaled allergens  
No 
Yes 
 
117/189 
30/40 
 
1.00 
1.85 (0.85; 4.00) 
 
 
0.12 
Specifying those for the first group awareness / those for all patients. Boldfaced text indicates statistical significance. 356 
Allergen sensitization: specific IgE ≥0.35kU/L. multiple senstizations to food allergen is defined as two or more specific allergen sensitizations.  357 
358 
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Table 2:  Estimated multivariate OR of variables at baseline associated to sensitization to inhaled allergens at the end of 359 
follow up  360 
 361 
Covariables at baseline Multivariate models  
 OR (CI 95%)   p-value 
Total IgE level 
Low 
High 
 
1.00 
1.52 (0.72;  3.21) 
0.27 
Sensitization to food allergens 
No 
Single food sensitization  
Multiple food sensitizations 
 
1.00 
2.20 (1.01; 4.72) 
3.72 (1.68; 8.30) 
 
 
0.05 
0.0012 
 362 
Allergen sensitization: specific IgE≥0.35kU/L. Multiple senstization to food allergen is defined as sensitization to two or more 363 
specific allergens. Risk factors associated with allergic sensitization to inhaled allergens in the univariate analysis (p<0.2) are 364 
included in the multivariate analysis. Boldface values indicate statistical significance. 365 
 366 
 367 
 368 
 369 
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